The safety, tolerability, pharmacokinetics, and pharmacodynamics of nebulized pegylated interferon α-2b in healthy adults: a randomized phase 1 trial. [PDF]
Huang W +9 more
europepmc +1 more source
Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial. [PDF]
Wang H +17 more
europepmc +1 more source
A machine learning-based predictive model for 48-week hepatitis B surface antigen seroclearance in chronic hepatitis B patients treated with pegylated interferon α-2b: prediction at week 24. [PDF]
Kong N +7 more
europepmc +1 more source
Nanomedicines in the treatment of chronic hepatitis C - focus on pegylated interferon alpha-2a [PDF]
Foster, G, Thomas, T
core
Dystonia during pegylated interferon alpha therapy in a case with essential thrombocythemia and cerebral infarction. [PDF]
Zhang P +6 more
europepmc +1 more source
Efficacy and safety of pegylated interferon in the treatment of JAK2<sup>V617F</sup>-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study. [PDF]
Chang L, Li WX, Cai H, Li J, Duan MH.
europepmc +1 more source
RNA Sequencing Analysis of Patients with Chronic Hepatitis B Treated Using PEGylated Interferon. [PDF]
Chen SL, Shen YJ, Chen GZ.
europepmc +1 more source

